Examkin

Tüm alıştırma soruları

771 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 761Soru →

A 5454-year-old man with acute myeloid leukemia is admitted to the hospital with a fever of 39.4∘C39.4^\circ C (102.9∘F102.9^\circ F) and chills. He received induction chemotherapy 1010 days ago. His blood pressure is 110/70110/70 mmHg and heart rate is 112112/min. Laboratory studies show an absolute neutrophil count of 200/μL200/\mu L. He has an indwelling central venous catheter in place. Arrange the following steps in the correct chronological sequence for the standard diagnostic evaluation, therapeutic intervention, and longitudinal monitoring of this patient's high-risk febrile neutropenia.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first obtain blood cultures, immediately follow with empiric broad-spectrum antipseudomonal antibiotics, monitor clinical response and cultures at 4848 to 7272 hours, and finally initiate empiric antifungal therapy if fever and severe neutropenia persist beyond 44 to 77 days.
High-risk febrile neutropenia is a medical emergency requiring a strict, standardized sequential approach. It begins with immediate acquisition of blood cultures (both peripheral and central) to identify the pathogen. Because these patients can deteriorate rapidly from overwhelming bacterial sepsis, this is followed immediately by the administration of empiric broad-spectrum antibiotics covering Pseudomonas aeruginosa (e.g., cefepime). Once therapy is initiated, the patient must be monitored closely, with a structured clinical and microbiological reassessment at the 4848- to 7272-hour mark. If the patient remains persistently febrile and profoundly neutropenic beyond 44 to 77 days without an identified source, occult fungal infection becomes highly probable, and empiric antifungal therapy (e.g., an echinocandin or azole) is added to the regimen.

Adım Adım Çözüm

1
Obtain blood cultures before initiating any antibiotics.
Maximizes the chance of identifying the causative bacterial pathogen.
Antibiotic administration prior to culture collection drastically reduces microbiological yield and compromises targeted therapy later.
2
Administer empiric broad-spectrum antipseudomonal antibiotics.
Provides immediate coverage against high-mortality pathogens like Pseudomonas aeruginosa.
Neutropenic patients lack the normal inflammatory immune response to contain infections, leading to rapid progression to septic shock if untreated.
3
Reassess clinical status and preliminary culture data at 4848 to 7272 hours.
Determines if current empiric therapy is effective or if source control or antibiotic modifications are needed.
It takes approximately 4848 to 7272 hours for most standard bacterial cultures to yield preliminary results and for clinical defervescence to occur on appropriate therapy.
4
Add empiric antifungal therapy at 44 to 77 days if the patient is still febrile.
Treats potential occult invasive fungal infections.
Prolonged severe neutropenia accompanied by persistent fever unresponsive to broad-spectrum antibacterial agents is a classic presentation for invasive fungal disease.

Anahtar Kavram

Standard management timeline and protocol for high-risk febrile neutropenia.
Soru 762Soru →

A 68-year-old man is admitted to the intensive care unit with severe community-acquired pneumonia, altered mental status, and oliguria. His temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), heart rate is 128128/min, and respiratory rate is 2828/min. Initial blood pressure is 72/4072/40 mm Hg, corresponding to a mean arterial pressure (MAP) of 5050 mm Hg. Peripheral pulses are weak, and capillary refill time is prolonged. Blood cultures and sputum cultures are drawn, and empiric broad-spectrum intravenous antibiotics are administered promptly. However, he remains persistently hypotensive with poor peripheral perfusion.

Arrange the following interventions in the correct guideline-directed sequential order for the management of this patient's shock. Assume the patient's MAP remains below the target of 6565 mm Hg despite the optimal titration of each preceding intervention.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential order for managing septic shock is: intravenous balanced crystalloids, followed by norepinephrine, followed by vasopressin, and finally intravenous hydrocortisone.
The Surviving Sepsis Campaign guidelines recommend a specific stepwise approach to hemodynamic optimization in septic shock. First, immediate fluid resuscitation with 3030 mL/kg of crystalloids is necessary to restore preload. If hypotension (MAP <65< 65 mm Hg) persists after fluids, norepinephrine is the first-line vasopressor. If the MAP target is still not met, vasopressin (typically at 0.030.03 units/min) is added as a second-line agent to augment mean arterial pressure and reduce the required norepinephrine dose. Finally, for shock that is refractory to adequate fluid loading and multiple vasopressors, intravenous hydrocortisone is administered to treat suspected critical illness-related corticosteroid insufficiency.

Adım Adım Çözüm

1
Identify the patient's condition
The patient is experiencing septic shock due to severe pneumonia, indicated by profound hypotension (MAP of 5050 mm Hg) and signs of end-organ dysfunction.
Recognizing the etiology of shock is critical for applying the correct treatment algorithm.
2
Determine the initial resuscitative step
Rapid administration of 3030 mL/kg of balanced crystalloids is required.
Intravenous fluids are the mandatory first step to correct absolute or relative hypovolemia and optimize preload before initiating vasoactive medications.
3
Select the first-line vasopressor
Initiate continuous intravenous norepinephrine.
Current guidelines designate norepinephrine as the first-line vasoactive agent for patients whose MAP remains below 6565 mm Hg despite adequate fluid resuscitation.
4
Determine the second-line escalation therapy
Add continuous intravenous vasopressin.
Vasopressin is added to augment MAP and decrease the required dosage of norepinephrine, mitigating catecholamine-induced toxicity.
5
Select therapy for refractory shock
Administer intravenous hydrocortisone.
For patients with refractory shock who remain hypotensive despite fluids and escalating doses of vasopressors, intravenous hydrocortisone at a stress dose of 200200 mg/day is recommended.

Anahtar Kavram

The stepwise pharmacologic escalation in septic shock prioritizes fluid resuscitation, followed by norepinephrine, then vasopressin, and finally corticosteroids for refractory cases.
Soru 763Soru →

An ambulatory patient in her late sixties presents to the clinic to discuss her bone health after recent screening tests. Her dual-energy x-ray absorptiometry (DEXA) demonstrates a lumbar spine T-score of −2.8-2.8 and a femoral neck T-score of −2.4-2.4. She has a history of hypertension but no prior fragility fractures. The physician and patient agree to initiate weekly oral alendronate. Arrange the following interventions in the most appropriate chronological order to safely initiate, monitor, and manage this patient's therapeutic course.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Verify baseline calcium/vitamin D, assess early adherence and tolerability, perform a follow-up DEXA scan at 1-2 years, and finally evaluate for a drug holiday at 3-5 years.
The correct sequence mirrors the natural timeline of patient management: safety screening immediately prior to initiation, early clinical monitoring for acute toxicity and adherence, mid-term evaluation of therapeutic efficacy via imaging, and long-term evaluation for cumulative risks necessitating therapy de-escalation.

Adım Adım Çözüm

1
Determine the prerequisites for initiation.
Serum calcium and vitamin D levels must be checked.
Bisphosphonates inhibit bone resorption, which can precipitate severe hypocalcemia if the patient lacks adequate calcium and vitamin D stores at baseline.
2
Identify early monitoring requirements.
Clinical follow-up for adherence and gastrointestinal side effects is prioritized next.
Oral nitrogen-containing bisphosphonates carry a high risk of erosive esophagitis and require strict administration protocols (taking with a full glass of water, remaining upright for 30 minutes). Early verification of adherence prevents acute harm.
3
Determine the interval for assessing intermediate drug efficacy.
A repeat DEXA scan is scheduled.
It takes at least 1 to 2 years for significant, measurable changes in bone mineral density to manifest on a DEXA scan. Earlier scanning does not provide clinically actionable data.
4
Determine the protocol for long-term treatment evaluation.
Assessment for a drug holiday is considered.
Because bisphosphonates accumulate in the bone matrix and have a very long half-life, a drug holiday is considered after 3 to 5 years of therapy to reduce the risk of long-term complications like atypical femur fractures.

Anahtar Kavram

The chronological protocol for monitoring and evaluating bisphosphonate therapy in patients with osteoporosis.
Soru 764Soru →

A 68-year-old man is admitted to the intensive care unit with worsening shortness of breath and progressive lethargy over the past 2 days. He has a history of ischemic cardiomyopathy. Upon arrival, he is obtunded, and his extremities are cold and mottled. Vital signs show a temperature of 36.8∘C36.8^\circ \text{C} (98.2∘F98.2^\circ \text{F}), blood pressure of 72/48 mm Hg72/48 \text{ mm Hg}, heart rate of 118/min118/\text{min}, and respiratory rate of 26/min26/\text{min}. Jugular venous distention is prominent. Lung auscultation reveals bilateral crackles. Cardiac examination shows a summation gallop. A pulmonary artery catheter reveals a cardiac index of 1.5 L/min/m21.5 \text{ L/min/m}^2 (normal: 2.5−4.02.5-4.0) and a pulmonary capillary wedge pressure of 28 mm Hg28 \text{ mm Hg} (normal: 4−124-12).

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute stabilization and subsequent management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Intravenous norepinephrine, followed by intravenous dobutamine, then intravenous furosemide, and finally oral bisoprolol.
The patient is presenting with 'cold and wet' cardiogenic shock, characterized by profound hypotension, hypoperfusion (lethargy, mottled extremities, low cardiac index), and congestion (crackles, elevated wedge pressure). The most immediate threat to life is the loss of critical perfusion pressure; therefore, restoring mean arterial pressure with a vasopressor (intravenous norepinephrine) is the absolute first step. Once a safe blood pressure foundation is established, an inotrope (intravenous dobutamine) is introduced to treat the primary pump failure and improve the cardiac index. Dobutamine cannot be given first due to its propensity to cause vasodilation and exacerbate severe hypotension. After forward flow and renal perfusion are adequately restored, it is safe to administer loop diuretics (intravenous furosemide) to address the volume overload without risking further ischemic acute kidney injury. Finally, guideline-directed medical therapies such as beta-blockers (oral bisoprolol) are strictly contraindicated in the acute phase due to their negative inotropic effects and are only carefully initiated once the patient is hemodynamically stable, euvolemic, and off vasoactive infusions.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome and immediate life-threatening derangement.
The patient is in cardiogenic shock ('cold and wet' phenotype) with a severely low cardiac index, elevated filling pressures, and profound hypotension (blood pressure 72/48 mm Hg72/48 \text{ mm Hg}).
Accurate categorization dictates the immediate resuscitation priorities.
2
Select the initial intervention to prevent imminent cardiovascular collapse.
Intravenous norepinephrine is chosen first.
Restoring a minimal mean arterial pressure is the absolute first priority to ensure cerebral and coronary perfusion. Norepinephrine provides robust alpha-1 mediated vasoconstriction.
3
Determine the next step to address the underlying low cardiac output state.
Intravenous dobutamine is added second.
Dobutamine improves myocardial contractility (beta-1 agonist), but its beta-2 mediated vasodilation can precipitate deadly hypotension if given before a vasopressor secures the blood pressure.
4
Address the volume overload (elevated pulmonary capillary wedge pressure).
Intravenous furosemide is administered third.
Aggressive diuresis in a severely hypotensive patient can worsen shock and precipitate acute kidney injury. It should be given only after establishing adequate forward flow and perfusion.
5
Plan for long-term morbidity and mortality reduction.
Oral bisoprolol is scheduled last.
Beta-blockers are strictly contraindicated in acute, uncompensated cardiogenic shock due to their negative inotropic effects. They are initiated only prior to discharge when the patient is stable.

Anahtar Kavram

In the management of profound cardiogenic shock ('cold and wet' phenotype with severe hypotension), the sequential priority is to first restore perfusion pressure with vasopressors, second improve cardiac output with inotropes, third relieve congestion with diuretics, and finally initiate long-term beta-blocker therapy only after stabilization.
Soru 765Soru →

An adult patient is admitted to the cardiac telemetry unit with acute decompensated heart failure, presenting with severe bilateral lower extremity edema, jugular venous distention, and orthopnea. The patient has an established history of heart failure with reduced ejection fraction and routinely takes 40 mg of oral furosemide daily at home. The inpatient medical team plans a structured, stepwise diuretic strategy to safely achieve euvolemia while preserving renal function. Arrange the following steps in the most appropriate chronological sequence for monitoring diuretic response and sequentially adapting treatment in this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is to first administer an initial IV loop diuretic, then evaluate urine sodium and output at 2 hours, double the IV loop diuretic dose if the initial response is inadequate, initiate sequential nephron blockade with a thiazide if maximum doses fail, and finally transition to an oral maintenance regimen once euvolemic.
The correct sequence mirrors the standardized guideline-directed algorithm for diuretic resistance in acute decompensated heart failure. It begins with establishing adequate initial IV dosing to bypass impaired gut absorption. Rather than waiting 24 hours, the response must be evaluated early (at 2 hours) via urine sodium or volume to adapt the treatment dynamically. If the threshold for diuresis is not met, the loop diuretic dose must be doubled to achieve an effective peak concentration. Only if the patient remains unresponsive at maximal loop diuretic doses should a thiazide-like diuretic be added to block compensatory distal sodium reabsorption. The final step is transitioning to oral therapy once euvolemia allows for reliable gut absorption.

Adım Adım Çözüm

1
Administer an initial IV bolus of a loop diuretic.
Delivers the diuretic directly to the systemic circulation.
Gut wall edema in acute decompensated heart failure significantly impairs the absorption of oral diuretics. IV administration bypasses this barrier.
2
Evaluate spot urine sodium and total urine output at the 2-hour mark.
Identifies early diuretic resistance.
Waiting 24 hours to assess daily output delays necessary care. The 2-hour assessment allows for rapid treatment adaptation and step-up therapy.
3
Double the IV loop diuretic dose if 2-hour targets are not achieved.
Increases the peak concentration of the diuretic.
Loop diuretics have a threshold effect. If the initial dose does not reach the necessary concentration in the tubular lumen, frequency adjustments will fail; the dose must be doubled.
4
Add a thiazide-like diuretic for persistent resistance.
Induces sequential nephron blockade.
Chronic loop diuretic use causes distal tubule hypertrophy. Adding a distally acting agent prevents the reabsorption of sodium that escapes the loop of Henle.
5
Transition to an oral maintenance regimen.
Prepares the patient for safe hospital discharge.
Once euvolemia is reached, gut absorption normalizes, allowing for a successful and stable switch back to oral pharmacotherapy.

Anahtar Kavram

Sequential step-up pharmacological therapy and rapid monitoring (e.g., 2-hour spot urine sodium) in acute decompensated heart failure.
Soru 766Soru →

A 53-year-old man is brought to the emergency department after falling from a 20-foot scaffolding. He is unresponsive and has a Glasgow Coma Scale score of 6 (Eye 1, Verbal 1, Motor 4). His pupils are equal and reactive, but he has a large right frontal hematoma. Vital signs are temperature 36.5°C (97.7°F), heart rate 108/min, blood pressure 172/98 mmHg, and respiratory rate 22/min. The trauma team decides to secure the airway via rapid sequence intubation (RSI) using a neuroprotective strategy to mitigate potential spikes in intracranial pressure. Pre-oxygenation with 100% oxygen is initiated.

Arrange the following pharmacologic agents in the correct chronological sequence of administration according to standard rapid sequence intubation protocols for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of administration is Fentanyl, followed by Etomidate, followed by Rocuronium, and finally a Propofol continuous infusion.
Standard rapid sequence intubation involves sequential phases: preparation, preoxygenation, pretreatment, paralysis with induction, positioning, placement, and post-intubation management. Pretreatment (such as fentanyl) mitigates the physiologic response to laryngoscopy and should be given first. Induction (etomidate) rapidly produces unconsciousness. Paralysis (rocuronium) must immediately follow induction to facilitate tube placement. Finally, post-intubation management requires starting a continuous sedative infusion (propofol) to ensure the patient does not awaken while still paralyzed by the long-acting neuromuscular blocker.

Adım Adım Çözüm

1
Administer pretreatment
Sympathetic blunting achieved
Intravenous fentanyl is given approximately 3 minutes before induction to prevent surges in intracranial pressure and blood pressure associated with airway manipulation.
2
Administer induction agent
Rapid unconsciousness induced
Intravenous etomidate is given as the induction agent to render the patient unconscious while maintaining hemodynamic stability.
3
Administer neuromuscular blockade
Complete chemical paralysis achieved
Intravenous rocuronium is pushed immediately after the patient loses consciousness to paralyze the vocal cords and skeletal muscles, facilitating endotracheal intubation.
4
Initiate post-intubation sedation
Ongoing sedation maintained
Once the endotracheal tube is confirmed, a continuous intravenous propofol infusion is started to keep the paralyzed patient adequately sedated.

Anahtar Kavram

Rapid Sequence Intubation (RSI) Pharmacologic Sequencing
Tahmini Süre:1m 0s
Soru 767Soru →

A 65-year-old woman is brought to the emergency department after a witnessed generalized tonic-clonic seizure. Her family reports she has been feeling progressively lethargic and confused over the past 3 days while recovering from a severe gastrointestinal illness. Initial laboratory evaluation reveals a serum sodium level of 112 mEq/L. She is diagnosed with severe symptomatic hyponatremia. Arrange the following management and monitoring steps in the correct chronological sequence, from initial emergency intervention to ongoing maintenance.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence involves immediate administration of 3% hypertonic saline to treat the seizure, followed by a rapid recheck of the sodium level at 20 minutes. Once symptoms resolve and sodium has increased by a safe margin of 4-6 mEq/L, the hypertonic saline is stopped. Management then transitions to cause-specific therapy, followed by ongoing monitoring every 6 to 8 hours to prevent overcorrection and osmotic demyelination syndrome.
Severe symptomatic hyponatremia requires a carefully phased approach to management and monitoring. The initial objective is to rapidly reverse life-threatening cerebral edema using a bolus of 3% hypertonic saline, followed by an immediate 20-minute sodium recheck to confirm the expected 1-2 mEq/L rise. Once the patient's acute symptoms (such as seizures) resolve and the sodium level has risen by a safe threshold of 4-6 mEq/L, the emergency phase is effectively complete. At this point, hypertonic saline must be discontinued to avoid rapid overcorrection. The management focus then shifts to cause-specific therapy directed at the underlying pathophysiology. Finally, less frequent but vigilant monitoring (every 6 to 8 hours) is instituted to ensure the 24-hour correction limit of 8 mEq/L is strictly maintained, which is critical for preventing osmotic demyelination syndrome.

Adım Adım Çözüm

1
Administer an initial 100-150 mL bolus of 3% hypertonic saline intravenously.
The hypertonic load begins to draw fluid out of the brain tissue.
To rapidly reverse life-threatening cerebral edema and stop the seizure activity.
2
Recheck the serum sodium concentration and reassess neurological status 20 minutes after the infusion.
The physician confirms whether the sodium has appropriately risen by 1-2 mEq/L.
To evaluate the immediate clinical response and determine if an additional hypertonic bolus is required.
3
Discontinue hypertonic saline once acute neurological symptoms resolve and sodium increases by 4-6 mEq/L.
The acute phase of therapy is safely terminated.
To prevent accidental overcorrection once the brain is out of immediate danger.
4
Transition to cause-specific therapy such as fluid restriction or isotonic fluids.
The patient begins maintenance therapy directed at the primary volume status and etiology.
To address the root cause of the hyponatremia now that the neurological emergency is stabilized.
5
Continue monitoring serum sodium every 6 to 8 hours to ensure 24-hour correction does not exceed 8 mEq/L.
The rate of sodium correction is strictly controlled over the subsequent days.
To prevent osmotic demyelination syndrome caused by excessively rapid sodium correction.

Anahtar Kavram

Monitoring and adjusting the rate of sodium correction in severe symptomatic hyponatremia
Soru 768Soru →

A 55-year-old man is brought to the emergency department via ambulance for severe shortness of breath, facial swelling, and a diffuse rash. His symptoms began 15 minutes ago while eating at a seafood restaurant. His medical history is significant for hypertension, hyperlipidemia, and a prior myocardial infarction. His home medications include metoprolol, atorvastatin, and aspirin. On physical examination, the patient is in severe respiratory distress with prominent stridor, accessory muscle use, and diffuse expiratory wheezing. Widespread urticaria is noted on his trunk and extremities. Vitals are temperature 37.1°C (98.8°F), blood pressure 72/40 mm Hg, pulse 62/min, and respiratory rate 28/min. Intravenous access is rapidly established by the nursing staff.

Arrange the following pharmacologic interventions in the most appropriate sequential order for the stepwise resuscitation and management of this patient, from the immediate life-saving therapy to the final adjunctive treatment.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of interventions is: 1) Administer intramuscular epinephrine, 2) Administer rapid intravenous normal saline bolus, 3) Administer intravenous glucagon, and 4) Administer intravenous methylprednisolone.
The correct sequence adheres to the standard stepwise protocol for acute anaphylaxis resuscitation. Intramuscular epinephrine is the universal first step to halt the allergic cascade and support hemodynamics. Because anaphylaxis is a severe distributive shock state, intravascular volume depletion must be rapidly corrected next with isotonic crystalloids. If the patient remains unstable, it is critical to recognize that his home metoprolol is blocking the beta-adrenergic effects of epinephrine, indicated by his lack of compensatory tachycardia (pulse 62/min). Therefore, glucagon must be administered as a targeted rescue agent because it bypasses the beta-receptor to increase intracellular cAMP. Finally, intravenous methylprednisolone is administered as an adjunctive measure to prevent a delayed biphasic reaction; it has no role in acute hemodynamic stabilization.

Adım Adım Çözüm

1
Administer intramuscular epinephrine.
Stimulates alpha-1, beta-1, and beta-2 receptors.
This is the unequivocal first-line, life-saving therapy for anaphylaxis. It must be administered immediately to reverse vasodilation, support blood pressure, and cause bronchodilation.
2
Administer rapid intravenous normal saline bolus.
Replenishes depleted intravascular volume.
Anaphylaxis causes severe distributive shock with massive capillary leak. Isotonic crystalloids are the standard fundamental resuscitation step initiated concurrently with or immediately following epinephrine.
3
Administer intravenous glucagon.
Activates adenylate cyclase independently of the beta-adrenergic receptor to increase intracellular cAMP.
The patient's pulse is 62/min despite profound shock, indicating that his home metoprolol is blunting the compensatory tachycardia and the efficacy of epinephrine. Glucagon is the specific escalation therapy for refractory anaphylaxis in beta-blocked patients.
4
Administer intravenous methylprednisolone.
Downregulates the late-phase systemic inflammatory response.
Corticosteroids play no role in the immediate reversal of acute anaphylactic shock. They are given as an adjunctive, final step to reduce the risk of a biphasic reaction hours later.

Anahtar Kavram

Stepwise escalation of pharmacologic therapy in anaphylactic shock, specifically addressing the management of epinephrine-refractory shock in patients taking beta-blockers.
Tahmini Süre:2m 0s
Soru 769Soru →

A 7272-year-old man is being evaluated in the intensive care unit for liberation from mechanical ventilation. He was admitted 99 days ago for acute respiratory distress syndrome secondary to severe influenza A pneumonia. His initial airway management was complicated, requiring three intubation attempts using video laryngoscopy. Today, his condition has markedly improved; he is hemodynamically stable off vasopressor support, and arterial blood gas analysis reveals a PaO 2_2 of 8585 mm Hg on a fraction of inspired oxygen (FiO 2_2) of 0.300.30 and a positive end-expiratory pressure (PEEP) of 55 cm H 2_2 O. The critical care team plans to systematically de-escalate his respiratory support. Arrange the following monitoring and therapeutic de-escalation steps in the most appropriate chronological sequence to safely liberate this patient from mechanical ventilation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The most appropriate sequence is: spontaneous awakening trial, followed by a spontaneous breathing trial, confirmation of adequate gas exchange, an endotracheal tube cuff leak test, and finally extubation.
Safe liberation from mechanical ventilation follows a standardized, chronological sequence. First, continuous sedatives must be interrupted (Spontaneous Awakening Trial) to allow the patient to demonstrate a normal respiratory drive and appropriate mental status. Second, a Spontaneous Breathing Trial (SBT) is initiated using minimal support to test the patient's ability to maintain the work of breathing. Third, objective physiological data, such as an arterial blood gas, are obtained toward the end of the SBT to verify adequate gas exchange. Fourth, because this patient is at high risk for laryngeal edema due to a prolonged (greater than 6 days) and traumatic intubation, a cuff leak test is specifically indicated to predict post-extubation stridor. Finally, if the cuff leak test is reassuring, the endotracheal tube is removed, and the patient is monitored closely for any signs of respiratory failure.

Adım Adım Çözüm

1
Perform a spontaneous awakening trial (SAT).
The patient regains consciousness and demonstrates a spontaneous respiratory effort.
Sedatives suppress respiratory drive and mask neurologic baseline; they must be paused to accurately assess the patient's capacity to breathe.
2
Initiate a spontaneous breathing trial (SBT).
The patient breathes independently with minimal pressure support.
Simulates post-extubation cardiopulmonary conditions to ensure the patient has sufficient reserve to breathe without the ventilator.
3
Assess objective gas exchange parameters.
Arterial blood gas confirms adequate oxygenation and absence of severe hypercapnia.
Provides objective physiological confirmation that the patient has successfully passed the SBT before planning removal of the tube.
4
Perform a cuff leak test.
An adequate air leak is detected when the endotracheal cuff is deflated.
To evaluate for laryngeal edema. This is strongly indicated in patients at high risk for airway narrowing due to prolonged (greater than 6 days) or traumatic intubations.
5
Extubate the patient.
The endotracheal tube is safely removed.
The final step in the de-escalation protocol once all safety, mechanical, and physiological criteria for liberation are met.

Anahtar Kavram

The systematic sequence for liberating a patient from mechanical ventilation involves paired awakening and breathing trials, followed by risk stratification for post-extubation airway complications prior to extubation.
Tahmini Süre:1m 0s
Soru 770Soru →

Following an emergency laparotomy for a perforated viscus, a 58-year-old male is transferred to the intensive care unit. He is intubated, sedated, and receiving broad-spectrum intravenous antibiotics. Despite the rapid administration of a 30 mL/kg intravenous crystalloid fluid bolus, his blood pressure remains 70/40 mmHg with a mean arterial pressure (MAP) of 50 mmHg. His extremities are warm to the touch, and bedside echocardiography demonstrates a hyperdynamic left ventricle. Arrange the following pharmacologic interventions in the most appropriate sequential order for escalating hemodynamic support in this patient, assuming he continuously fails to achieve the target MAP of ≥65\geq 65 mmHg after the implementation of each preceding step.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential order for escalating hemodynamic support in refractory septic shock is: 1) Norepinephrine, 2) Vasopressin, 3) Epinephrine, 4) Hydrocortisone.
According to the Surviving Sepsis Campaign guidelines, the pharmacologic management of septic shock unresponsive to initial fluid resuscitation follows a strict escalation protocol. Norepinephrine is the first-line vasopressor. If the MAP remains below 6565 mmHg, vasopressin is added as a second-line agent to spare catecholamine doses. If the patient remains hypotensive despite both norepinephrine and vasopressin, epinephrine is added as a third-line vasopressor. Finally, in patients with an ongoing requirement for vasopressor therapy despite these escalating steps, intravenous hydrocortisone is indicated to address critical illness-related corticosteroid insufficiency and improve vascular responsiveness.

Adım Adım Çözüm

1
Evaluate the response to initial fluid resuscitation.
The patient remains profoundly hypotensive (MAP < 65 mmHg) despite receiving an adequate 30 mL/kg crystalloid fluid bolus.
Vasopressors are indicated when fluid resuscitation fails to restore adequate perfusion and MAP.
2
Select and initiate the first-line vasopressor.
Norepinephrine is started as the primary vasoactive agent.
Norepinephrine provides balanced alpha and beta adrenergic stimulation, effectively increasing systemic vascular resistance with less risk of tachyarrhythmias compared to dopamine or pure epinephrine.
3
Escalate to a second-line agent if the MAP target is not met.
Vasopressin is added to the ongoing norepinephrine infusion.
Adding vasopressin acts via non-catecholamine receptors (V1) to increase vascular tone, which helps achieve the MAP target while sparing the need for excessively high, toxic doses of norepinephrine.
4
Escalate to a third-line agent if shock remains refractory.
Epinephrine is added to the regimen.
Epinephrine provides additional potent inotropic and chronotropic support, but is reserved as a third-line agent due to its potential to cause tachyarrhythmias and splanchnic ischemia.
5
Consider adjunctive non-vasopressor therapy.
Intravenous hydrocortisone is administered.
Corticosteroids treat potential critical illness-related corticosteroid insufficiency and help restore vascular responsiveness to catecholamines in patients with an ongoing requirement for vasopressor therapy.

Anahtar Kavram

Sequential Pharmacologic Escalation in Septic Shock
Tahmini Süre:1m 30s
Soru 771Soru →

A 64-year-old man with metastatic non-small cell lung cancer develops severe diarrhea (up to 10 watery stools daily) and abdominal cramping 4 weeks after initiating pembrolizumab therapy. His symptoms are classified as severe (Grade 3) immune-mediated colitis after infectious etiologies are ruled out and a colonoscopy confirms the diagnosis. He is admitted to the hospital for acute management. Arrange the following steps in the correct evidence-based sequence for the treatment, monitoring, and therapeutic de-escalation of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with stopping the checkpoint inhibitor and starting high-dose intravenous corticosteroids, followed by a 48 to 72-hour monitoring period. Due to a lack of improvement, a biologic agent (infliximab) is administered, after which the patient is transitioned to oral steroids upon symptom resolution, followed finally by a slow 4 to 6-week taper.
The evidence-based sequence for severe (Grade 3 or 4) immune-mediated colitis starts with permanent discontinuation of the offending agent alongside high-dose intravenous corticosteroids. A critical monitoring window of 48 to 72 hours follows to assess steroid responsiveness. If symptoms are refractory, therapy is escalated to a biologic agent (e.g., infliximab). Once symptoms improve to Grade 1, intravenous steroids are transitioned to oral forms, which must then be tapered very gradually over 4 to 6 weeks to prevent rebound flares.

Adım Adım Çözüm

1
Identify the severity and initiate first-line therapy.
Pembrolizumab is discontinued and high-dose intravenous methylprednisolone is started.
Grade 3 immune-mediated colitis requires immediate cessation of the offending agent and profound immunosuppression to halt the autoimmune response.
2
Establish a monitoring timeframe.
The patient is closely observed for 48 to 72 hours.
This is the standard clinical window to determine if the immune-related adverse event is steroid-responsive or steroid-refractory.
3
Escalate therapy for steroid-refractory disease.
Infliximab is administered.
Failure to improve within 48 to 72 hours on high-dose steroids necessitates the addition of a biologic agent like a TNF-alpha inhibitor.
4
De-escalate to oral therapy upon improvement.
Intravenous steroids are switched to oral prednisone.
Once symptoms improve to Grade 1 or baseline, parenteral therapy is no longer required and oral transition facilitates outpatient management.
5
Implement a long-term taper.
Corticosteroids are tapered over 4 to 6 weeks.
Rapid withdrawal of corticosteroids can lead to a severe rebound flare of the immune-mediated adverse event.

Anahtar Kavram

Management of severe immune checkpoint inhibitor-mediated colitis involves immediate cessation of the drug, initiation of high-dose corticosteroids, monitoring for 48 to 72 hours, escalation to biologic therapy if refractory, and a subsequent slow corticosteroid taper.
ÖncekiSayfa 39 / 39
Tüm alıştırma soruları — USMLE Step 3 | Examkin